CD1a MicroBeads have been developed for positive selection of CD1a+ dendritic cells from epidermis (Langerhans cells), dermis, lung, mucosa, and other non-lymphoid tissues or for further purification of CD1a+ dendritic cells generated ex vivo from CD34+ or CD133+ hematopoietic progenitor cells.
Non-human primate CD2 MicroBeads have been developed for positive selection or depletion of T cells and NK cells from rhesus monkey PBMCs.
CD20 MicroBeads were developed for the positive selection or depletion of B cells from rhesus monkey PBMCs or single-cell suspensions from tissue.
CD22 MicroBeads were developed for positive selection or depletion of human B cells from PBMCs, bone marrow, or single-cell suspensions from lymphoid tissues.
CD23 MicroBeads were developed for the positive selection or depletion of mouse B cell subsets from various lymphoid tissues based on the expression of the CD23 antigen.